266 related articles for article (PubMed ID: 30348601)
1. Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
Spronk PER; Volders JH; van den Tol P; Smorenburg CH; Vrancken Peeters MTFD
Eur J Surg Oncol; 2019 Feb; 45(2):110-117. PubMed ID: 30348601
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy in breast-conserving surgery - Consequences on margin status and excision volumes: A nationwide pathology study.
Volders JH; Haloua MH; Krekel NM; Negenborn VL; Barbé E; Sietses C; Jóźwiak K; Meijer S; van den Tol MP;
Eur J Surg Oncol; 2016 Jul; 42(7):986-93. PubMed ID: 27211343
[TBL] [Abstract][Full Text] [Related]
4. Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome.
van Hemert A; van Loevezijn AA; Bosman A; Vlahu CA; Loo CE; Peeters MTFDV; van Duijnhoven FH; van der Ploeg IMC
Breast Cancer Res Treat; 2024 Apr; 204(3):497-507. PubMed ID: 38189904
[TBL] [Abstract][Full Text] [Related]
5. Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.
Truin W; Vugts G; Roumen RM; Maaskant-Braat AJ; Nieuwenhuijzen GA; van der Heiden-van der Loo M; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2016 Jan; 23(1):51-7. PubMed ID: 25980321
[TBL] [Abstract][Full Text] [Related]
6. Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study.
Simons JM; Jacobs JG; Roijers JP; Beek MA; Boonman-de Winter LJM; Rijken AM; Gobardhan PD; Wijsman JH; Tetteroo E; Heijns JB; Yick CY; Luiten EJT
Breast Cancer Res Treat; 2021 Jan; 185(2):441-451. PubMed ID: 33073303
[TBL] [Abstract][Full Text] [Related]
7. National Trends in the Use of Neoadjuvant Chemotherapy for Hormone Receptor-Negative Breast Cancer: A National Cancer Data Base Study.
Puig CA; Hoskin TL; Day CN; Habermann EB; Boughey JC
Ann Surg Oncol; 2017 May; 24(5):1242-1250. PubMed ID: 28000076
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors associated with involved margins in breast cancer treated with neoadjuvant chemotherapy followed by breast-conserving therapy.
Davoine E; Dion L; Nyangoh Timoh K; Beraud E; Tas P; Tavenard A; Laviolle B; Perrin C; Foucher F; Levêque J; Lavoué V
J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):467-472. PubMed ID: 31207391
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Neoadjuvant Chemotherapy on Margin Re-excision in Breast-Conserving Surgery.
Devane LA; Baban CK; O'Doherty A; Quinn C; McDermott EW; Prichard RS
World J Surg; 2020 May; 44(5):1547-1551. PubMed ID: 32002582
[TBL] [Abstract][Full Text] [Related]
10. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
Kantor O; Ajmani G; Wang CH; Datta A; Yao K
Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
[TBL] [Abstract][Full Text] [Related]
11. Margin Assessment and Re-excision Rates for Patients Who Have Neoadjuvant Chemotherapy and Breast-Conserving Surgery.
Cen C; Chun J; Kaplowitz E; Axelrod D; Shapiro R; Guth A; Schnabel F
Ann Surg Oncol; 2021 Sep; 28(9):5142-5148. PubMed ID: 33635409
[TBL] [Abstract][Full Text] [Related]
12. Breast-Contour-Preserving Procedure as a Multidisciplinary Parameter of Esthetic Outcome in Breast Cancer Treatment in The Netherlands.
van Bommel A; Spronk P; Mureau M; Siesling S; Smorenburg C; Tollenaar R; Vrancken Peeters MJ; van Dalen T
Ann Surg Oncol; 2019 Jun; 26(6):1704-1711. PubMed ID: 30830541
[TBL] [Abstract][Full Text] [Related]
13. Overall survival in patients with a re-excision following breast conserving surgery compared to those without in a large population-based cohort.
Vos EL; Jager A; Verhoef C; Voogd AC; Koppert LB
Eur J Cancer; 2015 Feb; 51(3):282-91. PubMed ID: 25549530
[TBL] [Abstract][Full Text] [Related]
14. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Care in the Administration of Neo-adjuvant Chemotherapy for Breast Cancer. A Population-Based Study.
Vugts G; Maaskant-Braat AJ; Nieuwenhuijzen GA; Roumen RM; Luiten EJ; Voogd AC
Breast J; 2016 May; 22(3):316-21. PubMed ID: 26945566
[TBL] [Abstract][Full Text] [Related]
16. Predictors of re-excision among women undergoing breast-conserving surgery for cancer.
Waljee JF; Hu ES; Newman LA; Alderman AK
Ann Surg Oncol; 2008 May; 15(5):1297-303. PubMed ID: 18259820
[TBL] [Abstract][Full Text] [Related]
17. Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy?
Mamtani A; Sevilimedu V; Le T; Morrow M; Barrio AV
Cancer; 2022 Feb; 128(3):471-478. PubMed ID: 34597420
[TBL] [Abstract][Full Text] [Related]
18. Rationale for Mastectomy after Neoadjuvant Chemotherapy.
Gusic LH; Walsh K; Flippo-Morton T; Sarantou T; Boselli D; White RL
Am Surg; 2018 Jan; 84(1):126-132. PubMed ID: 29428039
[TBL] [Abstract][Full Text] [Related]
19. A prospective cohort study identifying radiologic and tumor related factors of importance for breast conserving surgery after neoadjuvant chemotherapy.
Gulis K; Ellbrant J; Svensjö T; Skarping I; Vallon-Christersson J; Loman N; Bendahl PO; Rydén L
Eur J Surg Oncol; 2023 Jul; 49(7):1189-1195. PubMed ID: 37019807
[TBL] [Abstract][Full Text] [Related]
20. How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery?
Petruolo O; Sevilimedu V; Montagna G; Le T; Morrow M; Barrio AV
Ann Surg Oncol; 2021 Jan; 28(1):287-294. PubMed ID: 32514804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
